Investing Profile

David Mott

InvestorVC

Private Investor at Mott Family Capital

Montana
Photo of David Mott, Investor at Mott Family Capital
Your Intro Paths to David Mott

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks David is a member of
New Enterprise Associates (NEA) Network
33 CONNECTIONS

Find David Mott on

cb
Current Investing Position
Mott Family Capital Investor
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
14

David Mott is on these Sector & Stage Rankings

David Mott's Investments On Record (10)

CompanyStageDateRound SizeTotal Raised
Sagimet Biosciences
Series EAug 2019$7M
$190M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Matthew McAviney (New Enterprise Associates (NEA)), Beth Seidenberg (Kleiner Perkins)
Nightstar Therapeutics
Series CJun 2017$45M
Series BNov 2015$35M
$80M
Ardelyx
Post-IPO EquityJul 2016$110M
Post-IPO EquityJun 2015$78M
Series BAug 2011$30M
$220M
Clementia Pharmaceuticals
Venture RoundJun 2015$60M
$93M
Co-investors: David Bonita (OrbiMed), Jean-François Pariseau (Amplitude VC)
Adaptimmune
Series ASep 2014$100M
$100M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA))
Cydan
Venture RoundOct 2013$10M
Venture RoundApr 2013$16M
$26M
Edimer Pharmaceuticals
Series BJul 2013$18M
$18M
Co-investors: Bernard Davitian (Omega Funds)
Prosensa
Venture RoundJan 2012€23M
€23M

David Mott's Experience

General Partner New Enterprise Associates (NEA)2008 - 2020

Founders who looked at David Mott's profile also looked at these Scouts & Angels

Photo of Jared Hecht, Angel

Photo of Kenneth Chenault, Managing Director at General Catalyst

General Catalyst